Entry Detail


General Information

Database ID:exR0451592
RNA Name:KIAA0232
RNA Type:mRNA
Chromosome:chr4
Starnd:+
Coordinate:
Start Site(bp):6781375End Site(bp):6884170
External Links:ENSG00000170871



Disease Information

Disease Name:
Disease Category:
MeSH ID:
Type:
Alias:



Expression Detail

GEO ID:GSE122377
Description:Tuberculous Meningitis in Pediatric Patients [CSF]
Experimental Design:Disease Sample Source
Case Disease Type:Pediatric TB meningitis
Case Disease SubType:NA
Case Sample:Ventricular Cerebrospinal Fluid
Control Sample:Lumbar Puncture Cerebrospinal Fluid
Number of Case:12
Number of Control:12
Number of Samples:24





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADRM1
chr20
62302093
62308862
+
ALDH3A2
chr17
19648136
19685760
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-130a-3p
chr11
57641252
57641273
+
hsa-miR-301a-3p
chr17
59151149
59151171
-
hsa-miR-130b-3p
chr22
21653354
21653375
+
hsa-miR-525-5p
chr19
53697547
53697567
+
hsa-miR-513a-5p
chrX
147213538
147213555
-
hsa-miR-671-5p
chr7
151238449
151238471
+
hsa-miR-454-3p
chr17
59137787
59137809
-
hsa-miR-362-3p
chrX
50009005
50009026
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC012321.1
chr16
69703065
69704652
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:31434901
Title:Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity
Author:Rohlwink UK, Figaji A, Wilkinson KA, Horswell S, Sesay AK, Deffur A, Enslin N, Solomons R, Van Toorn R, Eley B, Levin M, Wilkinson RJ, Lai RPJ
Journal:Nat Commun. 2019 Aug 21;10(1):3767.
Description:Differential transcript expression of TBM cases are compared with healthy controls in whole blood and with non-TB cerebral infection controls in CSF.